MX2011009808A - Agentes de elaboracion de imagen optica. - Google Patents

Agentes de elaboracion de imagen optica.

Info

Publication number
MX2011009808A
MX2011009808A MX2011009808A MX2011009808A MX2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A
Authority
MX
Mexico
Prior art keywords
optical imaging
imaging agents
agents
imaging contrast
kda
Prior art date
Application number
MX2011009808A
Other languages
English (en)
Spanish (es)
Inventor
Randall Lee Carter
Jason William Castle
Kenneth Michael Fish
Anup Sood
Natalie Anne Staples
Brian Dub-Ian Lee
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of MX2011009808A publication Critical patent/MX2011009808A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
MX2011009808A 2009-03-19 2010-03-19 Agentes de elaboracion de imagen optica. MX2011009808A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16153509P 2009-03-19 2009-03-19
PCT/EP2010/053619 WO2010106169A1 (en) 2009-03-19 2010-03-19 Optical imaging agents

Publications (1)

Publication Number Publication Date
MX2011009808A true MX2011009808A (es) 2011-09-30

Family

ID=42331047

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009808A MX2011009808A (es) 2009-03-19 2010-03-19 Agentes de elaboracion de imagen optica.

Country Status (11)

Country Link
US (1) US20120114563A1 (OSRAM)
EP (1) EP2413976A1 (OSRAM)
JP (1) JP2012520856A (OSRAM)
KR (1) KR20110138246A (OSRAM)
CN (1) CN102438659A (OSRAM)
AU (1) AU2010224789A1 (OSRAM)
BR (1) BRPI1009346A2 (OSRAM)
CA (1) CA2755770A1 (OSRAM)
MX (1) MX2011009808A (OSRAM)
RU (1) RU2011138096A (OSRAM)
WO (1) WO2010106169A1 (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201015806D0 (en) 2010-09-21 2010-10-27 Ge Healthcare As Vascular imaging agents
WO2012088007A1 (en) 2010-12-21 2012-06-28 Pierce Biotechnology, Inc. Fluorescent compounds
US8889884B1 (en) 2011-07-14 2014-11-18 Pierce Biotechnology, Inc. Phosphine derivatives of fluorescent compounds
DK2736533T3 (en) 2011-07-29 2018-08-06 Avelas Biosciences Inc SELECTIVE SUBMISSION MOLECULES AND METHODS OF USE
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
GB201116733D0 (en) 2011-09-28 2011-11-09 Ge Healthcare As Peptide margin imaging agents
US9751868B2 (en) 2012-02-28 2017-09-05 Pierce Biotechnology, Inc. Benzocyanine compounds
US20140072515A9 (en) 2012-03-02 2014-03-13 Greg Hermanson Cyanine compounds
JP6288970B2 (ja) * 2012-07-20 2018-03-07 キヤノン株式会社 化合物、および、前記化合物を有する光音響イメージング用造影剤
CN104470546B (zh) * 2012-07-20 2018-02-27 佳能株式会社 化合物和含有所述化合物的光声成像造影剂
WO2014035712A1 (en) 2012-08-28 2014-03-06 Pierce Biotechnology, Inc. Benzopyrylium compounds
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes
WO2014115206A1 (ja) * 2013-01-28 2014-07-31 独立行政法人科学技術振興機構 組織透明化方法、組織透明化試薬及び組織観察方法
CN105102484B (zh) 2013-01-30 2020-03-10 艾维拉斯生物科学公司 选择性递送分子及使用方法
FR3001463B1 (fr) * 2013-01-31 2015-02-20 Commissariat Energie Atomique Particules luminescentes de carbone, procede de preparation et utilisation
WO2015105549A2 (en) * 2013-10-02 2015-07-16 University Of Massachusetts Surface functionalized, host-guest polymer nano-assemblies and methods thereof
US9416276B2 (en) 2013-11-07 2016-08-16 Canon Kabushiki Kaisha Method for producing contrast agent
US10245329B2 (en) 2014-09-08 2019-04-02 Canon Kabushiki Kaisha Composition having dye and conjugate of polyethyleneglycol and additive and contrast agent for photoacoustic imaging having the same
WO2016060277A1 (en) 2014-10-16 2016-04-21 Canon Kabushiki Kaisha Polymer, and contrast agent for photoacoustic imaging, including the polymer
US10398788B2 (en) 2014-10-24 2019-09-03 Canon Kabushiki Kaisha Polymer and contrast agent for photoacoustic imaging including the polymer
JP6700750B2 (ja) 2014-12-09 2020-05-27 キヤノン株式会社 化合物、および、前記化合物を有する光学イメージング用造影剤
WO2016097317A1 (en) 2014-12-19 2016-06-23 Bracco Imaging Spa Intra-operative imaging
WO2016111915A1 (en) * 2015-01-06 2016-07-14 De Haas Anthony H Near-infrared fluorescent surgical dye markers
JP2017002000A (ja) * 2015-06-12 2017-01-05 キヤノン株式会社 化合物又はその薬学的に受容可能な塩、及び、前記化合物又はその薬学的に受容可能な塩を有する光音響イメージング用造影剤。
WO2017057653A1 (en) 2015-09-30 2017-04-06 Canon Kabushiki Kaisha Conjugate of polysarcosine and nir contrast agent for photoacoustic imaging
JP6789636B2 (ja) 2015-09-30 2020-11-25 キヤノン株式会社 重合体、前記重合体を有する光音響イメージング用造影剤
CN105688230B (zh) * 2016-02-02 2018-12-11 史春梦 七甲川吲哚花菁染料-聚乙二醇-叶酸复合物及制备方法和应用
CN109054013A (zh) * 2018-08-22 2018-12-21 东北大学 一种经修饰的吲哚菁绿及其制备方法
CN109738387A (zh) * 2018-12-29 2019-05-10 佛山科学技术学院 一种基于吲哚箐绿的光学相干层析成像方法和装置
WO2025197935A1 (ja) * 2024-03-19 2025-09-25 国立大学法人 東京大学 薬物－ポリマー複合体、医薬組成物、および薬物送達用ポリマー

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622685A (en) 1990-05-30 1997-04-22 Deutches Krebsforchunszentrum Stiftung Des Offentlichen Rechts Polyether-substituted porphyrin anti-tumor agents
DE4445065A1 (de) 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
DE69820867T2 (de) 1997-04-29 2004-11-18 Amersham Health As Lichtbilderzeugungskontrastmitteln
GB2337523A (en) * 1998-04-29 1999-11-24 Nycomed Imaging As Light imaging contrast agents
US20100143258A1 (en) * 2008-12-05 2010-06-10 General Electric Company Tumor margin imaging agents

Also Published As

Publication number Publication date
EP2413976A1 (en) 2012-02-08
US20120114563A1 (en) 2012-05-10
CA2755770A1 (en) 2010-09-23
BRPI1009346A2 (pt) 2017-05-30
JP2012520856A (ja) 2012-09-10
AU2010224789A1 (en) 2011-10-06
RU2011138096A (ru) 2013-04-27
CN102438659A (zh) 2012-05-02
WO2010106169A1 (en) 2010-09-23
KR20110138246A (ko) 2011-12-26

Similar Documents

Publication Publication Date Title
WO2009140423A3 (en) Targeted polymer bioconjugates
GB0718957D0 (en) Optical imaging agents
CY1125550T1 (el) Ορισμενες τριαζολοπυραζινες, συνθεσεις αυτων και μεθοδοι για τη χρηση αυτων
CY1125300T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν οξειδιο-υδροξειδιο του σιδηρου
WO2009112488A3 (en) Polyether polyol dendron conjugates with effector molecules for biological targeting
MX2012013375A (es) Peptido c pegilado.
EA201100268A1 (ru) Вакцина
MX2013014583A (es) Conjugados de proteina-polimero-farmaco.
JO3026B1 (ar) مستضادات ببتيد شبيه الجلوكاجون - 2
CY1117312T1 (el) Θεραπευτικη αγωγη συνουκλεϊνοπαθειων
MX2011012599A (es) Compuestos polimericos de agentes inmunomoduladores.
WO2017112825A3 (en) Polymer conjugates having reduced antigenicity and methods of using the same
BRPI0923047B8 (pt) métodos para preparação de conjugados de proteínas- oligossacarídeos
WO2011062965A3 (en) Targeting monomers and polymers having targeting blocks
EP2271359C0 (en) CONJUGATES OF CAMPTOTHECIN WITH BINDING MOLECULES
WO2010037069A3 (en) Dithienopyrrole dyes for imaging and therapy
IL206748A (en) Molecular test for @cancer @ breast cancer @
WO2008049758A3 (de) Dispersionsfarbstoffe, ihre herstellung und ihre verwendung
WO2011053901A3 (en) Magnetic nanostructures as theranostic agents
EP2633063A4 (en) CANCER IMAGING WITH THERAPY: THEROSIS
BR112013015825A2 (pt) composição selantes com cura térmica tendo rápida formação de membrana e alta resistência à tração.
CO6660443A2 (es) Factor viii conjugado para coagulación de la sangre a polietilenglicol (peg)
EA201170533A1 (ru) Высокодиспергируемый диоксид кремния для резин и способ его получения
WO2009098510A3 (en) Nanoparticle conjugates
WO2013040251A8 (en) Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal